Your Kidneys and Healthy Aging: What Every Adult Over 50 Should Know

Introduction

When patients come to see me about healthy aging, they usually want to talk about their heart, their memory, or their energy. They rarely ask about their kidneys. Yet these two fist-sized organs, tucked under your lower ribs on either side of your spine, quietly shape almost every one of those concerns. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), your kidneys filter about 150 quarts of blood a day, and they do far more than make urine. They help regulate blood pressure, balance salt and water in your body, keep your blood from becoming too acidic, activate vitamin D for your bones, and signal your bone marrow to make red blood cells.

Caring for your kidneys is stewardship for your whole body. The good news is that kidney decline is often slow; you can measure it with simple tests, and you can control much of the risk.

How Your Kidneys Change with Normal Aging

NIDDK explains that each kidney has about a million tiny filtering units called nephrons. As we age, some of these nephrons gradually scar and are lost, small arteries in the kidney stiffen, and the outer working layer of the kidney (the cortex) thins. Researchers at Mayo Clinic who studied carefully screened, healthy kidney donors found that glomerular filtration rate (GFR, the main measure of how well your kidneys filter) declines by about 6.3 mL/min/1.73 m2 per decade, or a bit under 1 point per year (Denic, 2016). That gentle downward slope typically begins somewhere around age 30-40.

Two other changes matter for daily life. First, older kidneys have less “renal reserve,” meaning less spare capacity to ramp up when illness, dehydration, surgery, or certain medications stress them. That is one reason older adults are at higher risk of acute kidney injury (Denic, 2016). Second, aging kidneys are less able to concentrate urine and conserve water, and a blunted sense of thirst makes dehydration more likely (Begg, 2017).

So how do you tell normal aging from disease? The Mayo team notes a real concern that some older adults are labeled with CKD when their numbers simply reflect age (Denic, 2016). Your clinician will look for three things: how low your eGFR is, whether it is falling faster than expected, and whether albumin (a protein) is leaking into your urine. Healthy aging lowers filtration a little. It should not cause significant albumin in the urine. When albumin shows up, or when eGFR drops more than about 20% between tests, that deserves attention (KDIGO, 2024).

Why Your Kidneys Matter for Your Heart

Your kidneys and your heart work as partners. The kidneys regulate blood pressure largely through the renin-angiotensin-aldosterone system, a hormonal chain that tightens blood vessels and holds on to salt and water when the kidneys sense low blood flow. When this system is overactive, blood pressure rises; higher blood pressure, in turn, damages the kidney’s delicate filters, and the cycle feeds itself. Physicians call this two-way relationship the cardiorenal connection.

The practical result is striking. In a large collaborative analysis of general population cohorts, both lower eGFR and higher urine albumin were each independently associated with higher risk of death from any cause and from cardiovascular disease, even after accounting for traditional risk factors such as blood pressure, diabetes, and cholesterol (Matsushita, 2010). A major review in The Lancet concluded that, after adjusting for traditional risk factors, reduced kidney function and raised urine albumin increase cardiovascular risk two to four times (Gansevoort, 2013). In other words, CKD multiplies cardiovascular risk. A 2004 study in the Archives of Internal Medicine followed nearly 28,000 Kaiser Permanente Northwest patients for about four years. Among those with stage 3 CKD, 24% died during that time, while only 1% started dialysis or received a kidney transplant.

Fluid, Salt, Potassium, and Acid Balance

Your kidneys keep your blood composition remarkably steady. They fine-tune sodium, which drives blood pressure and fluid retention, and potassium, which is essential for normal heart rhythm and muscle function. As kidney function declines, the body handles large swings in either mineral less gracefully, so if you have CKD, review medications and salt substitutes that contain potassium with your doctor.

Older adults face a particular hydration challenge. Studies consistently show that thirst in response to dehydration decreases with age, and the hormonal systems that conserve body water and sodium also change (Begg, 2017). Add diuretics, hot weather, or a stomach bug, and an older person can become dehydrated before feeling thirsty at all.

The kidneys also clear the acid produced by everyday metabolism. When kidney function falls, acid can build up in the blood (metabolic acidosis), which accelerates muscle breakdown, weakens bone, and appears to speed further kidney decline. This is why your diet’s composition, which I discuss below, matters so much.

Bones, Blood, and Vitamin D

Many people are surprised to learn that their kidneys help build their bones. The kidneys must convert vitamin D from sunlight or supplements into its active hormone form, calcitriol, which helps you absorb calcium. The kidneys also excrete excess phosphate. As kidney function declines, phosphate tends to accumulate; a bone-derived hormone called FGF23 rises to push phosphate out; active vitamin D falls; and the parathyroid glands respond by producing more parathyroid hormone (PTH). Over time, this chain of events, called CKD-mineral and bone disorder (CKD-MBD), can thin and weaken bone, raise fracture risk, and contribute to calcium deposits in blood vessels (KDIGO, 2024).

Your kidneys also produce erythropoietin, the hormone that tells your bone marrow to make red blood cells. When kidney function declines, erythropoietin production often falls, and anemia follows, showing up as fatigue, shortness of breath with exertion, and reduced stamina.

Frailty, Muscle, Thinking, and Independence

These threads come together in how you feel and function. Frailty, a state of reduced physical reserve marked by weakness, slowness, low activity, and exhaustion, is common in kidney disease. A 2024 meta-analysis found that 38.1% of people with CKD were frail and another 37.9% were pre-frail, with frailty linked to older age, lower grip strength, lower hemoglobin, and more medications (Li, 2024). Acidosis, anemia, inflammation, and reduced activity all erode muscle, and kidney disease also increases the risk of cognitive decline. The payoff for protecting your kidneys, then, is measured in very human terms: keeping your strength, your balance, your clarity, and your ability to live on your own terms.

Why CKD Is Called a “Silent” Disease

Early CKD rarely causes symptoms. You can lose half of your kidney function and feel entirely well. According to the US Renal Data System’s analysis of national survey data, 33.2% of Americans aged 65 and older had laboratory evidence of CKD (low eGFR, albumin in the urine, or both) in 2017-March 2020. Far fewer carry the diagnosis. The USRDS 2024 report found that in 2021, only 15.3% of fee-for-service Medicare beneficiaries aged 66 and older had a CKD diagnosis (19.4% in Medicare Advantage), and a CMS analysis found that over 70% of Medicare beneficiaries with lab results indicating CKD had no CKD diagnosis code. The CDC reports that about 9 in 10 (87%) adults with CKD do not know they have it. The gap between who has CKD and who has been told about it is the single biggest opportunity in kidney care.

Know Your Risk Factors

Diabetes and high blood pressure are the two leading causes of CKD, and obesity, cardiovascular disease, a family history of kidney disease, smoking, recurrent kidney stones, and simply being older all add to risk.

Underneath diabetes and hypertension sits a deeper metabolic story. Insulin resistance, when your cells respond poorly to insulin and your pancreas must pump out more of it (hyperinsulinemia), drives inflammation, raises blood pressure, and stresses the kidney’s filters years before blood sugar rises into the diabetic range. A systematic review and meta-analysis of 11 studies including more than 30,000 people found that metabolic syndrome (a cluster of abdominal obesity, high blood pressure, high triglycerides, low HDL cholesterol, and elevated blood sugar) was associated with 55% higher odds of developing an eGFR below 60, and the risk rose as the number of components increased (Thomas, 2011). Elevated uric acid often travels with this cluster and is worth tracking as a metabolic signal. Chronic low-grade inflammation links these conditions.

Medications deserve special attention. Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen can reduce blood flow to the kidneys. In a study of more than 10,000 adults aged 66 and older, high cumulative NSAID exposure was associated with an increased risk of rapid kidney function decline (Gooch, 2007). Proton-pump inhibitors (PPIs), the popular acid reflux medications such as omeprazole, have also been linked to kidney harm. In the Atherosclerosis Risk in Communities study, PPI use was associated with a 20-50% higher risk of incident CKD, while the older H2-blocker class was not (Lazarus, 2016). That study was observational and cannot prove cause and effect, but it is a good reason to review whether you still need a PPI. Other medications that can stress the kidneys include certain antibiotics, lithium, and some chemotherapy agents, and iodinated contrast dye used in CT scans can pose a risk to kidneys that are already weakened. Repeated dehydration also takes a cumulative toll.

The Tests That Find Kidney Disease Early

The current international kidney guideline from KDIGO (Kidney Disease: Improving Global Outcomes) recommends testing at-risk people for CKD with two tests: a blood test to estimate GFR and a urine test for albumin (KDIGO, 2024).

The blood test usually measures creatinine, a muscle waste product. Your lab calculates an estimated GFR (eGFR) from your creatinine level, age, and sex. Keep in mind that eGFR is exactly that: an estimate. Because creatinine comes from muscle, an older adult with low muscle mass may have a reassuringly “normal” creatinine that hides reduced kidney function, while a very muscular person may look worse on paper than they really are.

This is where cystatin C helps. Cystatin C is a protein made by nearly all cells, and it is much less affected by muscle mass. In a landmark analysis of 11 general population studies and 5 CKD cohorts, eGFR based on cystatin C, alone or combined with creatinine, predicted the risk of death and kidney failure more accurately than creatinine alone (Shlipak, 2013). The KDIGO guideline recommends using the combined creatinine-cystatin C equation when creatinine-based eGFR may be less accurate, and the result will affect clinical decisions (KDIGO, 2024). For many adults over 50, particularly those who are thin, frail, or have lost muscle, I consider cystatin C well worth adding.

The urine test is the urine albumin-to-creatinine ratio (uACR), measured on a simple spot sample. A value under 30 mg/g is normal, 30-300 mg/g is moderately increased, and above 300 mg/g is severely increased. Albumin in the urine is often the earliest sign of kidney damage, especially in diabetes and high blood pressure, and it frequently appears while eGFR is still normal.

KDIGO combines these two results into a color-coded “heat map” that grades risk from green (low) through yellow and orange to red (very high), based on your eGFR category and your albumin category together (KDIGO, 2024). Someone with a decent eGFR but significant albuminuria can land in a higher-risk box than someone with a modestly lower eGFR and no albumin. If you have diabetes, high blood pressure, cardiovascular disease, or a family history of kidney disease, ask for both tests at least once a year. If you already have CKD, your clinician will set the testing frequency based on your heat map category, typically 1 to 4 times a year.

Protecting Your Kidneys: Blood Pressure and Blood Sugar

Blood pressure control is the foundation. For most adults with CKD and high blood pressure, KDIGO suggests a systolic blood pressure target under 120 mm Hg when tolerated, measured with standardized office technique (Cheung, 2021). Individualize that target, especially if you are prone to dizziness or falls, and discuss it with your physician. Checking your blood pressure at home with a validated cuff gives you and your clinician far better information than an occasional office reading.

Glycemic control matters for anyone with diabetes or prediabetes, and in my practice I pay close attention to insulin levels as well as glucose, because insulin resistance can damage the kidneys long before HbA1c crosses into the diabetic range.

Eating for Your Kidneys

A plant-forward, whole-food dietary pattern is one of your most powerful tools. In the Atherosclerosis Risk in Communities study, which followed more than 14,000 middle-aged adults for up to 24 years, people who most closely followed a healthy plant-based diet or a pro-vegetarian diet had a lower risk of developing CKD and a slower decline in kidney function (Kim, 2019). The quality of plant foods matters: diets heavy in refined grains, sweets, and sugary drinks did not offer the same benefits. KDIGO now advises people with CKD to eat healthy, diverse diets with more plant-based foods than animal-based foods and fewer ultra-processed foods (KDIGO, 2024).

Part of the benefit appears to come from lowering your dietary acid load. Animal proteins and processed meats generate acid as they are metabolized, while fruits and vegetables produce alkali that buffers it. In a randomized trial of people with advanced hypertensive kidney disease and metabolic acidosis, adding base-producing fruits and vegetables corrected acidosis and reduced markers of kidney injury about as well as sodium bicarbonate, without raising potassium in carefully selected patients (Goraya, 2013).

In practice, build your meals around vegetables, fruits, legumes, whole grains, nuts, seeds, and olive oil, following the DASH and Mediterranean patterns. Choose plant proteins such as beans, lentils, and tofu, and limit red and processed meats. Lower your sodium by cooking at home and limiting packaged and restaurant foods. Potassium from whole plant foods generally supports blood pressure, but if you have moderate to advanced CKD or take medications that raise potassium, your clinician should check your levels before you increase it. For adults with CKD stages G3-G5, KDIGO recommends about 0.8 g of protein per kilogram of body weight per day, so avoid very high-protein diets without guidance (KDIGO, 2024).

Hydration, Movement, Weight, and Daily Habits

Because thirst becomes a less reliable guide as we age, older adults do better with a routine: sip water steadily throughout the day, drink a glass with each meal, and drink more in hot weather or when ill. Pale yellow urine is a reasonable everyday check. If you have heart failure or advanced CKD, your physician may want you to limit fluids instead, so follow their specific advice.

Regular physical activity, including both walking and strength training two or more days a week, helps control blood pressure, blood sugar, and weight, and it preserves the muscle that protects you from frailty. Losing excess weight, particularly abdominal fat, eases the strain on your kidneys. If you smoke, stopping is one of the best gifts you can give your blood vessels, including the tiny ones in your kidneys. Keep alcohol modest, and protect your sleep, since untreated sleep apnea and chronic short sleep both raise blood pressure.

Bring every medication and supplement you take, including over-the-counter pain relievers and acid reflux pills, to your clinician once a year for a review. For occasional pain, ask whether acetaminophen or topical options are safer for you than oral NSAIDs.

Medications That Slow Kidney Decline

Over the past several years, three classes of medication have changed what is possible for people with CKD. These are prescription decisions to make with your physician, never do-it-yourself projects, but you deserve to know they exist.

SGLT2 inhibitors were first developed for diabetes. In the DAPA-CKD trial, dapagliflozin lowered the risk of a combined outcome of major kidney function loss, kidney failure, or death from kidney or cardiovascular causes in people with CKD, whether or not they had diabetes (Heerspink, 2020). KDIGO now recommends this class for many people with CKD (KDIGO, 2024).

GLP-1 receptor agonists are best known for weight loss and diabetes. In the FLOW trial of people with type 2 diabetes and CKD, weekly semaglutide reduced the risk of major kidney events and cardiovascular death and slowed the yearly loss of eGFR (Perkovic, 2024).

Finerenone is a newer, nonsteroidal aldosterone receptor blocker. In the FIDELIO-DKD trial of people with CKD and type 2 diabetes, it lowered the risks of CKD progression and cardiovascular events, though it raises potassium in some patients and requires monitoring (Bakris, 2020).

Supplements With Solid Human Evidence

I keep supplement recommendations for kidney health short, because only a few have reliable human data. Long-chain omega-3 fatty acids from seafood are one. In a pooled analysis of 19 cohorts including more than 25,000 people, those with the highest blood levels of seafood-derived omega-3s had a 13% lower risk of developing CKD than those with the lowest levels, while plant-derived omega-3 (ALA) showed no association (Ong, 2023). Eating fatty fish such as salmon or sardines a couple of times a week, or discussing a fish oil supplement with your clinician, is reasonable.

If your blood test shows vitamin D deficiency, correcting it under medical guidance makes sense for bone health, especially as kidney function declines.

For people who already have CKD with metabolic acidosis, sodium bicarbonate prescribed and monitored by a physician has trial support. In a 2-year randomized trial of patients with advanced CKD and low bicarbonate levels, supplementation slowed the decline in kidney function and improved nutritional status (de Brito-Ashurst, 2009). This is a treatment for a measured problem, so please do not start baking soda on your own.

When to Seek Medical Guidance

Because early CKD is silent, symptoms usually appear late, but it’s worth knowing what to look for. See your clinician if you notice swelling in your ankles, feet, or around your eyes; persistently foamy or bubbly urine, which can signal protein; a change in how often or how much you urinate; getting up repeatedly at night to urinate; unusual fatigue or trouble concentrating; or blood pressure that stays high despite treatment. Catching CKD early gives you years in which lifestyle changes and modern medications can slow or even stabilize the decline, and it alerts your care team to adjust doses and avoid kidney-stressing drugs and procedures.

Kidney Health as Part of Your Longevity Plan

When I evaluate someone over 50 who wants to stay strong and independent for decades, I look at the kidneys alongside the heart, metabolism, and immune system, because they rise and fall together. A thoughtful, comprehensive metabolic panel goes beyond the basics to include eGFR from both creatinine and cystatin C, a urine albumin-to-creatinine ratio, fasting insulin, HbA1c, uric acid, and a full lipid profile. Together, these markers reveal insulin resistance, early kidney stress, and cardiovascular risk long before symptoms appear, which is exactly when you have the most power to change course.

Your kidneys have been working faithfully for you every minute of your life. With a few good habits and the right tests, you can return the favor and give yourself the best chance of enjoying the years ahead with energy, comfort, and independence.

References

1. Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383(23):2219-2229.
2. Begg DP. Disturbances of thirst and fluid balance associated with aging. Physiol Behav. 2017;178:28-34.
3. Cheung AK, Chang TI, Cushman WC, et al. Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3):559-569.
4. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20(9):2075-2084.
5. Denic A, Glassock RJ, Rule AD. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis. 2016;23(1):19-28.
6. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339-352.
7. Gooch K, Culleton BF, Manns BJ, Zhang J, Alfonso H, Tonelli M, et al. NSAID use and progression of chronic kidney disease. Am J Med. 2007;120(3):280.e1-280.e7.
8. Goraya N, Simoni J, Jo CH, Wesson DE. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol. 2013;8(3):371-381.
9. Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436-1446.
10. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117-S314.
11. Kim H, Caulfield LE, Garcia-Larsen V, Steffen LM, Grams ME, Coresh J, et al. Plant-based diets and incident CKD and kidney function. Clin J Am Soc Nephrol. 2019;14(5):682-691.
12. Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, et al. Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176(2):238-246.
13. Li BH, Sang N, Zhang MY, Liu ZR, Fang RX, Liu WJ, et al. The prevalence and influencing factors of frailty in patients with chronic kidney disease: a systematic review and meta-analysis. Int Urol Nephrol. 2024;56(2):767-779.
14. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073-2081.
15. Ong KL, Marklund M, Huang L, Rye KA, Hui N, Pan XF, et al. Association of omega 3 polyunsaturated fatty acids with incident chronic kidney disease: pooled analysis of 19 cohorts. BMJ. 2023;380:e072909.
16. Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, et al. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N Engl J Med. 2024;391(2):109-121.
17. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369(10):932-943.
18. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2011;6(10):2364-2373.